Skip to main content
SpringerLink
Log in

The feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Purposes

The benefit of neo-adjuvant chemotherapy for liver-limited metastatic colorectal cancer is still controversial. This study defined the resectability regardless of the size and number of liver metastases, and attempted curative hepatic resection in all cases.

Methods

Sixty-four patients that tolerated chemotherapy were diagnosed with CLM (colorectal liver metastases) without extrahepatic metastase from January 2007 to November 2010, and received an oxaliplatin-based regimen. This study assessed the resectability after chemotherapy, and the patients were divided in two groups; the resected and unresected group. Sixteen patients underwent hepatic resection without chemotherapy.

Results

Thirty-five patients underwent surgical resection (resected group) and twenty-nine patients were considered unresectable (unresected group). All 35 patients in the resected group safely received oxaliplatin-based chemotherapy safely without serious adverse effects. No serious postoperative complications were observed. The median overall survival (MST) was significantly higher in the resected than in the unresected group (56.93 [95 % CI 38.13–75.73] and 25.07 months [95 % CI 17.87–32.26], respectively; P < 0.001). The median disease-free survival was 20.2 [95 % CI 8.82–31.65] months in the resected group.

Conclusion

Preoperative chemotherapy for CLM is well tolerated and does not increase postoperative complications. Curative surgery with preoperative chemotherapy has the potential to improve the overall survival in patients with CLM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30.

    Article  PubMed  Google Scholar 

  2. Stangl R, Altendorf-Hoffman A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastasis. Lancet. 1994;343:1405–10.

    Article  PubMed  CAS  Google Scholar 

  3. Leonard GD, Brennner B, Kernery NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastasis from colorectal carcinoma. J Clin Oncol. 2005;23:2038–48.

    Article  PubMed  CAS  Google Scholar 

  4. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18.

    Article  PubMed  CAS  Google Scholar 

  5. Balducci G, Sagnotta A, Muroni M, et al. An unusual case of exclusive liver metastases from adenoid cystic carcinoma of the submandibular gland: a role for surgery? Report of a case. Surg Today. 2011;41(4):596–9.

    Article  PubMed  Google Scholar 

  6. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet. 2008;371:1007–16.

    Article  PubMed  CAS  Google Scholar 

  7. Folprecht G, Gruenberger T, Bechstein WO, et al. Tumor response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomized phase 2 trial. Lancet Oncol. 2010;11(1):38–47.

    Article  PubMed  CAS  Google Scholar 

  8. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2003;7:1034–44.

    Article  PubMed  Google Scholar 

  9. Fong Y, Bentrem DJ. CASH (chemotherapy-associated steatohepatitis) costs. Ann Surg. 2006;234:8–9.

    Article  Google Scholar 

  10. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–6.

    Article  PubMed  CAS  Google Scholar 

  11. Anderson CD, Chari RS. Chemotherapy liver injury. Surgery. 2010;147:195–6.

    Article  PubMed  Google Scholar 

  12. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–16.

    Article  PubMed  CAS  Google Scholar 

  13. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240(6):1052–61.

    Article  PubMed  Google Scholar 

  14. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:640–58.

    Article  Google Scholar 

  15. Adam R, Bhangui P, Poston G, et al. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases. Ann Surg. 2010;252:774–87.

    Article  PubMed  Google Scholar 

  16. Rees M, Tekkis PP, Welsh FK, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:715–24.

    Article  Google Scholar 

  17. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.

    Article  PubMed  Google Scholar 

  18. Niu R, Yan TD, Zhu JC, et al. Recurrence and survival outcomes after hepatic resection for colorectal metastases. Ann Surg Oncol. 2007;14:2078–87.

    Article  PubMed  Google Scholar 

  19. Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246:806–14.

    Article  PubMed  Google Scholar 

  20. De Haas RJ, Wicherts DA, Flores E, et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248:626–37.

    PubMed  Google Scholar 

  21. Connors S, Hart MG, Redhead DN, et al. Follow-up and outcomes for resection of colorectal liver metastases in Edinburgh. Eur J Surg Oncol. 2007;33:55–60.

    Article  Google Scholar 

  22. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–66.

    Article  PubMed  Google Scholar 

  23. Scheele J, Stangl R, Altendorf-Hoffmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19:59–71.

    Article  PubMed  CAS  Google Scholar 

  24. Jaeck D, Bachellier P, Guiguet M, et al. Long-term survival following resection of colorectal hepatic metastases: Association Francaise de Chirurgie. Br J Surg. 1997;84:977–80.

    Article  PubMed  CAS  Google Scholar 

  25. Adam R, Pascal G, Azoulay D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003;238:871–83.

    Article  PubMed  Google Scholar 

  26. Rivoire M, De Cian F, Meeus P, et al. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer. 2002;95:2283–92.

    Article  PubMed  CAS  Google Scholar 

  27. Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumor response and resection rates. Ann Oncol. 2005;16:1311–9.

    Article  PubMed  CAS  Google Scholar 

  28. Chua TC, Saxena A, Liauw W, et al. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol. 2010;17:492–501.

    Article  PubMed  Google Scholar 

  29. Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17(1):1–29.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Kozo Kataoka has no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Surgery, Osaka Red-Cross Hospital, 5-30, Fudegasaki, Tennnoji, Osaka, 543-8555, Japan

    Kozo Kataoka, Akiyoshi Kanazawa, Akio Nakajima, Ayane Yamaguchi, Akira Arimoto & Yukihiro Kohno

Authors
  1. Kozo Kataoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akiyoshi Kanazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akio Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ayane Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akira Arimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yukihiro Kohno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kozo Kataoka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kataoka, K., Kanazawa, A., Nakajima, A. et al. The feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study. Surg Today 43, 1154–1161 (2013). https://doi.org/10.1007/s00595-012-0410-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-012-0410-7

Keywords

Search

Navigation